Schalken JA - Search Results

1

Analysis of expression of chorionic gonadotrophin transcripts in prostate cancer by quantitative Taqman and a modified molecular beacon RT-PCR.

Span PN, Thomas CM, Heuvel JJ, Bosch RR, Schalken JA, vd Locht L, Mensink EJ, Sweep CG. Span PN, et al. Among authors: schalken ja. J Endocrinol. 2002 Mar;172(3):489-95. doi: 10.1677/joe.0.1720489. J Endocrinol. 2002. PMID: 11874697

2

Molecular methods for predicting the metastatic potential of prostate cancer.

Schalken JA. Schalken JA. Cancer Surv. 1991;11:43-54. Cancer Surv. 1991. PMID: 1726788 Review.

3

Oncogene expression in prostate cancer.

Schalken JA, Bussemakers MJ, Debruyne FM. Schalken JA, et al. Prog Clin Biol Res. 1990;357:97-105. Prog Clin Biol Res. 1990. PMID: 2217484 Review.

4

Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate.

Span PN, Schalken JA, Sweep FG, Smals AG. Span PN, et al. Among authors: schalken ja. Prostate. 1998 Feb 15;34(3):222-30. doi: 10.1002/(sici)1097-0045(19980215)34:3<222::aid-pros10>3.0.co;2-g. Prostate. 1998. PMID: 9492851

5

Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.

Span PN, Völler MC, Smals AG, Sweep FG, Schalken JA, Feneley MR, Kirby RS. Span PN, et al. Among authors: schalken ja. J Urol. 1999 Jan;161(1):332-7. J Urol. 1999. PMID: 10037433 Clinical Trial.

6

Molecular analysis of multifocal prostate cancer lesions.

Ruijter ET, Miller GJ, van de Kaa CA, van Bokhoven A, Bussemakers MJ, Debruyne FM, Ruiter DJ, Schalken JA. Ruijter ET, et al. Among authors: schalken ja. J Pathol. 1999 Jul;188(3):271-7. doi: 10.1002/(SICI)1096-9896(199907)188:3<271::AID-PATH359>3.0.CO;2-K. J Pathol. 1999. PMID: 10419595

7

Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors.

van Garderen E, van der Poel HJ, Swennenhuis JF, Wissink EH, Rutteman GR, Hellmén E, Mol JA, Schalken JA. van Garderen E, et al. Among authors: schalken ja. Endocrinology. 1999 Dec;140(12):5907-14. doi: 10.1210/endo.140.12.7189. Endocrinology. 1999. PMID: 10579357

8

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. Bussemakers MJ, et al. Among authors: schalken ja. Cancer Res. 1999 Dec 1;59(23):5975-9. Cancer Res. 1999. PMID: 10606244

9

Complex cadherin expression in human prostate cancer cells.

Bussemakers MJ, Van Bokhoven A, Tomita K, Jansen CF, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Int J Cancer. 2000 Feb 1;85(3):446-50. Int J Cancer. 2000. PMID: 10652439

10

Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer.

van der Graaf M, Schipper RG, Oosterhof GO, Schalken JA, Verhofstad AA, Heerschap A. van der Graaf M, et al. Among authors: schalken ja. MAGMA. 2000 Jul;10(3):153-9. doi: 10.1007/BF02590640. MAGMA. 2000. PMID: 10873205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters